Dolores Schendel

Chief Tech/Sci/R&D Officer at MEDIGENE AG

Net worth: 1 M $ as of 30/04/2024

Health Technology

Consumer Services

Miscellaneous

Dolores Schendel active positions

Companies	Position	Start	End
MEDIGENE AG	Chief Tech/Sci/R&D Officer	01/05/2014	-
MEDIGENE AG	Chief Executive Officer	31/08/2018	24/07/2022
MediGene, Inc. MediGene, Inc. Pharmaceuticals: MajorHealth Technology MediGene, Inc. develops herpes simplex virus technologies for the treatment of tumors and for gene delivery. The company was founded by Ram Bhatt and Frank Tufaro and is headquartered in San Diego, CA.	Chief Executive Officer	-	-

Career history of Dolores Schendel

Former positions of Dolores Schendel

Companies	Position	Start	End
Institute of Molecular Immunology	Director/Board Member	01/01/1998	01/01/2013
European Research Council European Research Council Investment Trusts/Mutual FundsMiscellaneous The European Research Council is an organization that provides grants for research projects. The organization is based in Brussels, Belgium. As a grantee, individuals are required to submit scientific and financial reports for assessment by ERC Scientific Officers. The organization emphasizes the importance of research ethics and compliance with legislation, disciplinary norms, and protection of research subjects. The responsibility for ethics lies with the individuals conducting the research, while the formal accountability lies with the signatory of the Grant Agreement, the Host Institution.	Corporate Officer/Principal	-	-
German Cancer Aid	Corporate Officer/Principal	-	-
Deutsche Forschungsgemeinschaft	Corporate Officer/Principal	-	-
Medigene Immunotherapies GmbH Medigene Immunotherapies GmbH Pharmaceuticals: MajorHealth Technology Part of MediGene AG, Medigene Immunotherapies GmbH develops immunotherapy to treat cancer. The company is based in Planegg, Germany. The German company was founded in 2013 by Thomas Blankenstein, Dolores J. Schendel. The CEO is Axel-Sven Malkomes. Medigene Immunotherapies was acquired by MediGene AG on January 27, 2014 for $13.05 million.	Chief Executive Officer	01/05/2014	-
	Founder	01/05/2014	-
Ludwig-Maximilians-Universität München	Corporate Officer/Principal	-	-

Training of Dolores Schendel

University of Wisconsin

Doctorate Degree

Statistics

International

Germany	7
United States	3
Belgium	2

Operational

Corporate Officer/Principal	4
Chief Executive Officer	3
Chief Tech/Sci/R&D Officer	1

Sectoral

Health Technology	4
Consumer Services	4
Miscellaneous	2

Positions held

Active

Inactive

Listed companies

Private companies

Linked companies

Listed companies	1
MEDIGENE AG	Health Technology

Private companies	5
MediGene, Inc. MediGene, Inc. Pharmaceuticals: MajorHealth Technology MediGene, Inc. develops herpes simplex virus technologies for the treatment of tumors and for gene delivery. The company was founded by Ram Bhatt and Frank Tufaro and is headquartered in San Diego, CA.	Health Technology
European Research Council European Research Council Investment Trusts/Mutual FundsMiscellaneous The European Research Council is an organization that provides grants for research projects. The organization is based in Brussels, Belgium. As a grantee, individuals are required to submit scientific and financial reports for assessment by ERC Scientific Officers. The organization emphasizes the importance of research ethics and compliance with legislation, disciplinary norms, and protection of research subjects. The responsibility for ethics lies with the individuals conducting the research, while the formal accountability lies with the signatory of the Grant Agreement, the Host Institution.	Miscellaneous
Institute of Molecular Immunology
Medigene Immunotherapies GmbH Medigene Immunotherapies GmbH Pharmaceuticals: MajorHealth Technology Part of MediGene AG, Medigene Immunotherapies GmbH develops immunotherapy to treat cancer. The company is based in Planegg, Germany. The German company was founded in 2013 by Thomas Blankenstein, Dolores J. Schendel. The CEO is Axel-Sven Malkomes. Medigene Immunotherapies was acquired by MediGene AG on January 27, 2014 for $13.05 million.	Health Technology
German Cancer Aid

See company connections